Ultralife Corporation (ULBI) is a publicly traded Industrials sector company. As of May 21, 2026, ULBI trades at $6.12 with a market cap of $101.61M and a P/E ratio of -0.15. ULBI moved +0.17% today. Year to date, ULBI is +0.17%; over the trailing twelve months it is +7.73%. Its 52-week range spans $4.07 to $10.09. Rallies surfaces ULBI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate ULBI?
The average price target is $0.00.
ULBI Key Metrics
Key financial metrics for ULBI
Metric
Value
Price
$6.12
Market Cap
$101.61M
P/E Ratio
-0.15
EPS
$-38.11
Dividend Yield
0.00%
52-Week High
$10.09
52-Week Low
$4.07
Volume
106
Avg Volume
0
Revenue (TTM)
$187.86M
Net Income
$-8.30M
Gross Margin
23.09%
ULBI Analyst Consensus
ULBI analyst coverage data. Average price target: $0.00.